# Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

> **NCT01034683** · PHASE3 · UNKNOWN · sponsor: **Taian Cancer Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Esophageal Carcinoma

## Interventions

- **DRUG:** lobaplatin , 5-FU ,leucovorin

## Key facts

- **NCT ID:** NCT01034683
- **Lead sponsor:** Taian Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034683, "Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT01034683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*